(Q57904812)

English

Serum concentrations of angiogenic cytokines in Waldenstrom macroglobulinaemia: the ratio of angiopoietin-1 to angiopoietin-2 and angiogenin correlate with disease severity

article

In more languages

Statements

scholarly article

0 references

Serum concentrations of angiogenic cytokines in Waldenstrom macroglobulinaemia: the ratio of angiopoietin-1 to angiopoietin-2 and angiogenin correlate with disease severity (English)

0 references

serum concentration

1 reference

based on heuristic

inferred from title

Efstathios Kastritis

object named as

Efstathios Kastritis

4

0 references

Athanasios Dimopoulos

8

object named as

Meletios A. Dimopoulos

0 references

Evangelos Terpos

9

object named as

Evangelos Terpos

0 references

Konstantinos Tsionos

5

object named as

Konstantinos Tsionos

0 references

7

object named as

John Meletis

0 references

Aristotelis Bamias

6

object named as

Aristotelis Bamias

0 references

author name string

Vangelis Eleftherakis-Papaiakovou

2

0 references

Konstantinos Zervas

3

0 references

Athanasios Anagnostopoulos

1

0 references

language of work or name

0 references

publication date

June 2007

0 references

British Journal of Haematology

0 references

137

0 references

6

0 references

560-568

0 references

Relation between bone marrow angiogenesis and serum levels of angiogenin in patients with myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06609.X

21 January 2018

Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06609.X

21 January 2018

Angiogenesis in life, disease and medicine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06609.X

21 January 2018

Targeting VEGF-A to treat cancer and age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06609.X

21 January 2018

Prognostic model for disease-specific and overall mortality in newly diagnosed symptomatic patients with Waldenstrom macroglobulinaemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06609.X

21 January 2018

Signaling vascular morphogenesis and maintenance

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06609.X

21 January 2018

The combination of intermediate doses of thalidomide and dexamethasone reduces bone marrow micro-vessel density but not serum levels of angiogenic cytokines in patients with refractory/relapsed multiple myeloma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06609.X

21 January 2018

Angiogenins: a new class of microbicidal proteins involved in innate immunity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06609.X

21 January 2018

Actin is a binding protein for angiogenin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06609.X

21 January 2018

Bone marrow angiogenic ability and expression of angiogenic cytokines in myeloma: evidence favoring loss of marrow angiogenesis inhibitory activity with disease progression.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06609.X

21 January 2018

Angiogenesis and hematological malignancies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06609.X

21 January 2018

Angiopoietins and angiopoietin-like proteins in angiogenesis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06609.X

21 January 2018

Suppression of angiogenesis and tumor growth by selective inhibition of angiopoietin-2

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06609.X

21 January 2018

Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06609.X

21 January 2018

The small-molecule VEGF receptor inhibitor pazopanib (GW786034B) targets both tumor and endothelial cells in multiple myeloma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06609.X

21 January 2018

Anti-angiogenic effect of bortezomib in patients with multiple myeloma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06609.X

21 January 2018

Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06609.X

21 January 2018

Angiogenesis in Waldenstrom's macroglobulinemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06609.X

21 January 2018

Angiogenin: a review of the pathophysiology and potential clinical applications

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06609.X

21 January 2018

Thalidomide downregulates angiogenic genes in bone marrow endothelial cells of patients with active multiple myeloma.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06609.X

21 January 2018

Identifiers

10.1111/J.1365-2141.2007.06609.X

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57904812&oldid=2164833306"